Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 14, 2001 10:56 ET | Source: Active Biotech

The Active Biotech Group Interim Report January - March 2001

The operations of Active Biotech currently focus on the development of pharmaceuticals and vaccines. In Lund, the company conducts pharmaceutical research and development and has very promising...
May 09, 2001 11:22 ET | Source: Active Biotech

Active Biotech-koncernen Kvartalsrapport januari-mars 2001

I Lund bedriver bolaget forsknings- och utvecklingsverksamhet av läkemedel med mycket lovande projekt, bl. a inom MS och cancer. Bolagets verksamhet i Stockholm innefattar utveckling, tillverkning...
April 24, 2001 03:20 ET | Source: Active Biotech

Active Biotech fulfills important milestone for the SAIK-MS project

The clinical Phase 1 study on Active Biotech’s SAIK-MS compound, ABR-215062 in healthy volunteers and MS patients is concluded. The study has successfully reached its clinical endpoint, and has...
April 24, 2001 03:18 ET | Source: Active Biotech

Active Biotech har uppnått viktigt delmål inom SAIK-MS projektet

Den kliniska Fas I-studien av Active Biotechs substans SAIK-MS (ABR-215062), där friska frivilliga personer och MS-patienter deltagit, har nu avslutats. Det kliniska målet för studien har uppnåtts...
March 30, 2001 02:59 ET | Source: Active Biotech

Annual General Meeting of Shareholders in Active Biotech 29 March 2001

At Active Biotech AB´s Annual General Meeting Sven Andréasson, Mats Arnhög, Maria Borelius, Svend Holst-Nielsen, Mats Pettersson, Peter Sjöstrand and Hugo Thelin were re-elected. Hugo Thelin will...
March 30, 2001 02:03 ET | Source: Active Biotech

Bolagsstämma i Active Biotech AB den 29 mars 2001

Vid Active Biotech ABs ordinarie bolagsstämma omvaldes Sven Andréasson, Mats Arnhög, Maria Borelius, Svend Holst-Nielsen, Mats Pettersson, Peter Sjöstrand och Hugo Thelin. Hugo Thelin kommer även...
March 23, 2001 07:05 ET | Source: Active Biotech

Active Biotech in collaboration with Aventis Pasteur MSD regarding distribution and marketing of vaccines in Sweden

Active Biotech AB, through its subsidiary SBL Vaccin AB, and Aventis Pasteur MSD announce that they will initiate a collaboration regarding marketing and distribution of vaccines, and will now start a...
March 23, 2001 07:05 ET | Source: Active Biotech

Active Biotech i samarbete med Aventis Pasteur MSD kring distribution och marknadsföring av vacciner i Sverige

Active Biotech AB, genom sitt dotterbolag SBL Vaccin AB, och Aventis Pasteur MSD meddelar att de kommer inleda ett nära samarbete avseende marknadsföring och distribution av vacciner på den svenska...
February 27, 2001 04:34 ET | Source: Active Biotech

Active Biotech: Kallelse till bolagsstämma

Active Biotech AB:s (publ) styrelse har idag utfärdat kallelse till årets ordinarie bolagsstämma, vilken kommer äga rum torsdagen den 29 mars 2001 kl. 17.00 på Scandic Star Hotel, Glimmervägen 5,...
February 27, 2001 04:32 ET | Source: Active Biotech

Active Biotech: Invitation to Annual General Meeting of Shareholders

The Board of Directors of Active Biotech AB (publ) has today issued a notification of the Annual General Meeting, which is to take place at 17.00 on 29 March 2001 at the Scandic Star Hotel,...